The Neutrophil-to-lymphocyte ratio as a diagnostic and prognostic biomarker in pulmonary hypertension: A systematic review.
Sarcoidosis vasculitis and diffuse lung diseases · 25.06.2025 · 42 (2) · 14552-14552
DOI: 10.36141/svdld.v42i2.14552 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 25.06.2025. Verfasst von Shokoufeh Khanzadeh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: The objective of this systematic review is to provide an overview of research that examined the relationship between pulmonary hypertension (PH) and the neutrophil-to-lymphocyte ratio (NLR). METHODS: To identify the studies related to NLR, a search was done on PubMed, Scopus, and Web of Science with an end date of March 30th, 2023. A total of 25 studies were included in the review. These studies included a variety of pathologies that contribute to PH. We employed the Newcastle-Ottawa Scale to assess the quality of studies. For all studies, a significance level of P˂0.05 was used. RESULTS: In patients with sarcoidosis, chronic obstructive pulmonary disease, systemic sclerosis, chronic kidney disease, and congenital heart disease, NLR appears to be an independent predictor of PH. Also, it was frequently linked to the result, complications, and severity of the disease in PH patients. CONCLUSION: NLR may be utilized as a repeatable, inexpensive, and trustworthy proxy for the onset and severity of PH.
Schlagwörter
Autor:innen und Institutionen
- Department of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Medicine, Arak University of Medical Sciences, Arak, Iran.
- Department of Neurosurgery, University of Florida, Gainesville, USA.
- Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Cardiology, Kosuyolu Heart Education and Research Hospital, University of Health Sciences, Istanbul, Turkey.
- Department of Cardiovascular Medicine, Charles University and General University Hospital, Prague, Czech Republic.
ORCID-Profile: Shima Nourigheimasi
Zitieren
APA
Khanzadeh, S., Aminizadeh, S., Nourigheimasi, S., Lucke-Wold, B., Rashidi, F., Kaymaz, C., Janda, P., Reis, A., Goutnik, M., Khanzadeh, M., Bazrafshan Drissi, H., & Chichagi, F. (2025). The Neutrophil-to-lymphocyte ratio as a diagnostic and prognostic biomarker in pulmonary hypertension: A systematic review. Sarcoidosis vasculitis and diffuse lung diseases, 42(2), 14552-14552. https://doi.org/10.36141/svdld.v42i2.14552
Vancouver
Khanzadeh S, Aminizadeh S, Nourigheimasi S, Lucke-Wold B, Rashidi F, Kaymaz C, et al. The Neutrophil-to-lymphocyte ratio as a diagnostic and prognostic biomarker in pulmonary hypertension: A systematic review. Sarcoidosis vasculitis and diffuse lung diseases. 2025;42(2):14552-14552. doi:10.36141/svdld.v42i2.14552
BibTeX
@article{Khanzadeh2025,
author = {Khanzadeh, Shokoufeh and Aminizadeh, Sarina and Nourigheimasi, Shima and Lucke-Wold, Brandon and Rashidi, Farid and Kaymaz, Cihangir and Janda, Pavel and Reis, Abilio and Goutnik, Michael and Khanzadeh, Monireh and Bazrafshan Drissi, Hamed and Chichagi, Fatemeh},
title = {The Neutrophil-to-lymphocyte ratio as a diagnostic and prognostic biomarker in pulmonary hypertension: A systematic review},
journal = {Sarcoidosis vasculitis and diffuse lung diseases},
year = {2025},
volume = {42},
number = {2},
pages = {14552--14552},
doi = {10.36141/svdld.v42i2.14552}
}
EUVIMED